×
Entrez Id:
287
Gene Symbol:
ANK2
ANK2
Brugada Syndrome (disorder)
0.300
Biomarker
CLINGEN
"Defining the cellular phenotype of ""ankyrin-B syndrome"" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes."
17242276
2007
×
Entrez Id:
23171
Gene Symbol:
GPD1L
GPD1L
Brugada Syndrome (disorder)
0.360
Biomarker
CLINGEN
GPD1L does not appear to be a major cause of Brugada syndrome in the Japanese population.
18762705
2008
×
Entrez Id:
29098
Gene Symbol:
RANGRF
RANGRF
Brugada Syndrome (disorder)
0.550
Biomarker
CLINGEN
MOG1 was screened by direct sequencing in patients with BrS and idiopathic ventricular fibrillation.
21447824
2011
×
Entrez Id:
54795
Gene Symbol:
TRPM4
TRPM4
Brugada Syndrome (disorder)
0.530
GermlineCausalMutation
ORPHANET
TRPM4 mutations account for about 6% of BrS .
23382873
2013
×
Entrez Id:
54795
Gene Symbol:
TRPM4
TRPM4
Brugada Syndrome (disorder)
0.530
SusceptibilityMutation
ORPHANET
TRPM4 mutations account for about 6% of BrS .
23382873
2013
×
Entrez Id:
54795
Gene Symbol:
TRPM4
TRPM4
Brugada Syndrome (disorder)
0.530
Biomarker
CLINGEN
TRPM4 mutations account for about 6% of BrS .
23382873
2013
×
Entrez Id:
6324
Gene Symbol:
SCN1B
SCN1B
Brugada Syndrome (disorder)
0.550
Biomarker
CLINGEN
SCN1B mutations have been associated with Brugada syndrome as well as with other cardiac arrhythmias and familial epilepsy.
25253298
2014
×
Entrez Id:
23171
Gene Symbol:
GPD1L
GPD1L
Brugada Syndrome (disorder)
0.360
Biomarker
CLINGEN
A GPD1-L mutation decreases SCN5A surface membrane expression, reduces inward Na+ current, and causes Brugada syndrome .
17967977
2007
×
Entrez Id:
55800
Gene Symbol:
SCN3B
SCN3B
Brugada Syndrome (disorder)
0.530
Biomarker
CLINGEN
A missense mutation (L10P) was detected in exon 1 of SCN3B , the beta 3 subunit of the cardiac sodium channel, but not in any other gene known to be associated with Brugada syndrome or in 296 controls.
20031595
2009
×
Entrez Id:
6331
Gene Symbol:
SCN5A
SCN5A
Brugada Syndrome (disorder)
1.000
Biomarker
CTD_human
A mutation in the cardiac sodium channel gene (SCN5A ) has been described in patients with the syndrome of right bundle branch block, ST-segment elevation in leads V1 to V3, and sudden death (Brugada syndrome ).
10662748
2000
×
Entrez Id:
3757
Gene Symbol:
KCNH2
KCNH2
Brugada Syndrome (disorder)
0.450
Biomarker
CLINGEN
A novel KCNH2 mutation as a modifier for short QT interval.
18692916
2009
×
Entrez Id:
29098
Gene Symbol:
RANGRF
RANGRF
Brugada Syndrome (disorder)
0.550
Biomarker
CLINGEN
A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmias.
21621375
2011
×
Entrez Id:
6324
Gene Symbol:
SCN1B
SCN1B
Brugada Syndrome (disorder)
0.550
Biomarker
CTD_human
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
22155597
2012
×
Entrez Id:
6324
Gene Symbol:
SCN1B
SCN1B
Brugada Syndrome (disorder)
0.550
Biomarker
CLINGEN
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
22155597
2012
×
Entrez Id:
6336
Gene Symbol:
SCN10A
SCN10A
Brugada Syndrome (disorder)
0.800
Biomarker
CLINGEN
A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A.
9839820
1998
×
Entrez Id:
10060
Gene Symbol:
ABCC9
ABCC9
Brugada Syndrome (disorder)
0.510
Biomarker
GENOMICS_ENGLAND
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.
24439875
2014
×
Entrez Id:
10060
Gene Symbol:
ABCC9
ABCC9
Brugada Syndrome (disorder)
0.510
GermlineCausalMutation
ORPHANET
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.
24439875
2014
×
Entrez Id:
783
Gene Symbol:
CACNB2
CACNB2
Brugada Syndrome (disorder)
0.510
Biomarker
CLINGEN
Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome.
19358333
2009
×
Entrez Id:
6331
Gene Symbol:
SCN5A
SCN5A
Brugada Syndrome (disorder)
1.000
Biomarker
CTD_human
Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?
20513597
2010
×
Entrez Id:
3757
Gene Symbol:
KCNH2
KCNH2
Brugada Syndrome (disorder)
0.450
Biomarker
CLINGEN
Additional next generation sequencing analyses revealed the p.R25W mutation in KCNH2 gene in SCN5A-negative BrS patients.
25626866
2015
×
Entrez Id:
54795
Gene Symbol:
TRPM4
TRPM4
Brugada Syndrome (disorder)
0.530
Biomarker
CLINGEN
Among the 45 genotyped patients, only one presented a SCN5A mutation, whereas a TRPM4 mutation was found in another patient.Both belonged to BrS group II.
23293604
2012
CACNA2D1
Brugada Syndrome (disorder)
0.620
Biomarker
CLINGEN
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.
24309898
2014
×
Entrez Id:
5318
Gene Symbol:
PKP2
PKP2
Brugada Syndrome (disorder)
0.650
Biomarker
CLINGEN
Arrhythmogenic cardiomyopathy and provocable Brugada ECG in a patient caused by missense mutation in plakophilin-2.
24681023
2014
×
Entrez Id:
6336
Gene Symbol:
SCN10A
SCN10A
Brugada Syndrome (disorder)
0.800
Biomarker
CLINGEN
Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.
22723299
2012
×
Entrez Id:
6331
Gene Symbol:
SCN5A
SCN5A
Brugada Syndrome (disorder)
1.000
Biomarker
CTD_human
Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine.
19875396
2010